Chugai Pharmaceutical : Q3 Results (Jan-Sep 2023) -October 24, 2023 at 04:16 am EDT

NOTICE: For the convenience of capital market participants, Chugai makes efforts to provide English translations of the information disclosed in Japanese, provided that the Japanese...

Related Keywords

Tokyo ,Japan ,Japanese ,Osamu Okuda ,Kae Miyata ,European Commission ,Alexion Pharmaceuticals Inc ,International Accounting Standards ,Chugai Pharmaceutical Co Ltd ,Committee For Medicinal Products Human Use ,International Accounting Standard ,Drug Administration ,European Medicines Agency ,Head Of Corporate Communications Department ,Tokyo Stock Exchange ,Early Retirement Incentive Program ,Name Of Company ,International Financial Reporting Standards ,Corporate Communications Department ,Quarterly Marketable Securities Filings ,Dividend Payments ,Materials Prepared ,Quarterly Financial Statements ,Condensed Consolidated Financial Statements ,Major Notes ,Alexion Pharmaceuticals ,Chugai Life Science Park Yokohama ,Supplementary Materials ,Consolidated Financial Results ,Fiscal Year ,Medicinal Products ,Human Use ,Fujieda Plant ,Financial Statements ,Cash Flows ,Markets ,